Conference on drug discovery set for March 29

A daylong conference on drug discovery will bring together leaders and researchers in academia, industry and government.

The 2016 Stanford Drug Discovery Conference is scheduled from from 9 a.m. to 5:30 p.m. March 29 at the Li Ka Shing Center for Learning and Knowledge.

The conference is designed to bring together the collective experience of experts in drug discovery to discuss advances in research and technology. It will feature talks by leaders and researchers in academia, industry and government. Keynote speakers are Nobel laureate Brian Kobilka, MD, professor molecular and cellular physiology at Stanford; Christopher Austin, MD, director of the National Center for Advancing Translational Sciences; and Jessica Mega, MD, chief medical officer at Verily Life Sciences.

The event is free and open to the public. For more information or to register, visit the Stanford Cardiovascular Institute website

About Stanford Medicine

Stanford Medicine is an integrated academic health system comprising the Stanford School of Medicine and adult and pediatric health care delivery systems. Together, they harness the full potential of biomedicine through collaborative research, education and clinical care for patients. For more information, please visit med.stanford.edu.

2023 ISSUE 3

Exploring ways AI is applied to health care